Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Aclasta°


Contraindicated
Reproductive toxicity in animals

Contraindicated
Aclasta° :
Type Medicine Withdrawn
Originator B
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Responsible Party Novartis Pharma AG
Origin Switzerland
Manufacturer Fresenius Kabi Austria GmbH
Origin Austria
ATC M05BA08
Revision Date 01/06/2012

Your comment will appear shortly after approval

Aclasta° :

Revision Date : 01/06/2012


Effect Frequency
Abdominal pain Uncommon
Acute phase reaction Uncommon
Anaemia Uncommon
Anaphylactic reactions Very rare
Anaphylactic shock Very rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Rare
Anorexia Uncommon
Anxiety Uncommon
Arthralgia (Pain joint) (Joint ache) Common
Arthritis Uncommon
Asthenia Common
Atrial fibrillation Uncommon
Back pain Common
Blood creatinine increased Uncommon
Bone pain Common
Bronchoconstriction Rare
Cephalea Common
Chills Common
Conjunctivitis Uncommon
Constipation Uncommon
Cough Uncommon
Decreased appetite Uncommon
Dehydration Not known
Diaphyseal femoral fractures Not known
Diarrhoea (Diarrhea) Common
Dizziness Common
Dry mouth (Xerostomia) Uncommon
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Uncommon
Dyspepsia Uncommon
Dyspnoea (dyspnea) Uncommon
Epigastralgia (Epigastric pain) Uncommon
Episcleritis Rare
Erythema Uncommon
Eye pain Uncommon
Fatigue Common
Fever Very Common
Flank pain Uncommon
Flushing Uncommon
Gastritis Uncommon
Gastrooesophageal reflux disease Uncommon
Hyperhidrosis Uncommon
Hypertension Uncommon
Hypocalcaemia Uncommon
Hypoesthesia Uncommon
Hypotension Not known
Influenza Uncommon
Influenza-like symptoms Common
Injection site pain Uncommon
Injection site redness Uncommon
Injection site swelling Uncommon
Insomnia Uncommon
Iritis Rare
Jaw pain Common
Joint stiffness Uncommon
Joint swelling Uncommon
Lethargy Uncommon
Malaise Common
Muscle spasms Uncommon
Muscle weakness Uncommon
Musculoskeletal chest pain Uncommon
Musculoskeletal pain Uncommon
Musculoskeletal stiffness Uncommon
Myalgia Common
Nasopharyngitis Uncommon
Nausea Common
Neck pain Uncommon
Night sweats Common
Non-cardiac chest pain Uncommon
Oedema peripheral Uncommon
Oesophagitis Uncommon
Orbital inflammation Not known
Osteonecrosis of the jaw Very rare
Pain Common
Pain in extremity (Pain in limb) Common
Paraesthesia (paresthesia) Uncommon
Pollakiuria (Urinary frequency) Uncommon
Proteinuria Uncommon
Pruritus Uncommon
Renal insufficiency Uncommon
scleritis Not known
Shoulder pain Uncommon
Skin rash Uncommon
Somnolence Uncommon
Subtrochanteric femoral fractures Not known
Syncope Uncommon
Thirst Uncommon
Tremor Uncommon
Urticaria Rare
Uveitis Rare
Vertigo Uncommon
Vision blurred Uncommon
Vomiting Common

Different Units By MoH Code

Revision Date : 11/10/2021

Revision Date : 11/10/2021

Aclasta°  MoH 4043 :
Form Solution for infusion
Packaging Plastic vial (oleofinic polymer))
Package Size 100ml
Package Content 100 ml solution in a transparent plastic (cycloolefinic polymer) bottle closed with a fluoro-polymer coated bromobutyl rubber stopper and an aluminium/polypropylene cap with a flip component.
Strength 5mg
NSSF ✘
Quarantine ✔
Reg. Number 24667/07
Submission date 01/01/2007
Registration Year 2007
Withdrawn Date 13/06/2024


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info